Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus

Journal of the National Cancer Institute

Volumn 94, Issue 23, 2002, Pages 1757-1763

  Gutiérrez, Marina I ^a   Ibrahim, Muna M ^a   Dale, Janet K ^b   Greiner, Timothy C ^c   Straus, Stephen E ^b   Bhatia, Kishor ^c  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; EPSTEIN BARR VIRUS; GENE CONTROL; GENE MUTATION; HUMAN; HUMAN CELL; INFECTIOUS MONONUCLEOSIS; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; NONHODGKIN LYMPHOMA; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE; SERODIAGNOSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; STATISTICAL ANALYSIS; TUMOR GROWTH; VIRUS INFECTION; VIRUS REPLICATION; VIRUS STRAIN;

EID: 0037021668     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.23.1757     Document Type: Article

References (31)

1. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000;343:481-92.
2. Miller G. The switch between latency and replication of Epstein-Barr virus. J Infect Dis 1990;161:833-44.
3. Faulkner GC, Krajewski AS, Crawford DH. The ins and outs of EBV infection. Trends Microbiol 2000;8:185-9.
4. Niedobitek G, Agathanggelou A, Steven N, Young LS. Epstein-Barr virus (EBV) in infectious mononucleosis: detection of the virus in tonsillar B lymphocytes but not in desquamated oropharyngeal epithelial cells. Mol Pathol 2000;53:37-42.
5. van Esser JW, van der Holt B, Meijer E, Niesters HG, Trenschel R, Thijsen SF, et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 2001;98:972-8.
6. Takada K, Ono Y. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J Virol 1989;63:445-9.
7. Chang YN, Dong DL, Hayward GS, Hayward DS. The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif. J Virol 1990;64:3358-69.
8. Flemington E, Speck S. Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol 1990;64:1217-26.
9. Flemington E, Speck SH. Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol 1990;64:1227-32.
10. Borras AM, Strominger JL, Speck SH. Characterization of the ZI domains in the Epstein-Barr virus BZLF1 gene promoter: role in phorbol ester induction. J Virol 1996;70:3894-901.
11. Faggioni A, Zompetta C, Grimaldi S, Barile G, Frati L, Lazdins J. Calcium modulation activates Epstein-Barr virus genome in latently infected cells. Science 1986;232:1554-6.
12. Fahmi H, Cochet C, Hmama Z, Oolon P, Joab I. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway. J Virol 2000;74:5810-8.
13. Shimizu N, Takada K. Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence. J Virol 1993;67:3240-5.
14. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, et al. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B and EBNA-3C genes. J Virol 1990;64:4084-92.
15. Lin JC, Lin SC, De BK, Chan WC, Evatt BL, Chan WC. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease. Blood 1993;81:3372-81.
16. Srivastava G, Wong KY, Chiang AK, Lam KY, Tao Q. Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state. Blood 2000;95:2443-5.
17. Chen HL, Lung ML, Chan KH, Griffin BE, Ng MH. Tissue distribution of Epstein-Barr virus genotypes. J Virol 1996;70:7301-5.
18. Buck M, Cross S, Krauer K, Kienzle N, Sculley TB. A-type and B-type Epstein-Barr virus differ in their ability to spontaneously enter the lytic cycle. J Gen Virol 1999;80:441-5.
19. Takada K. Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt's lymphoma lines. Int J Cancer 1984;33:27-32.
20. Countryman J, Jenson H, Seibl R, Wolf H, Miller G. Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J Virol 1987;61:3672-9.
21. Jenson HB, Miller G. Polymorphisms of the region of the Epstein-Barr virus genome which disrupts latency. Virology 1988;165:549-64.
22. Packham G, Brimmell M, Cook D, Sinclair AJ, Farrell PJ. Strain variation in Epstein-Barr virus immediate early genes. Virology 1993;192:541-50.
23. Gutiérrez MI, Hamdy N, Bhatia K, Bornkamm G, Lenoir G, Epelman S, et al. Geographic variation in t(8;14) chromosomal breakpoint locations and EBV association in Burkitt's lymphoma. Int J Pediatr Hematol Oncol 1999;6:161-8.
24. Gutiérrez MI, Kingma DW, Sorbara L, Tran M, Rafteld M, Jaffe ES, et al. Association of EBV strains, defined by multiple loci analyses, in non-Hodgkin's lymphomas and reactive tissues from HIV positive and HIV negative patients. Leuk Lymphoma 2000;37:425-9.
25. Gutiérrez MI, Raj A, Spangler G, Sharma A, Hussain A, Judde JG, et al. Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells. J Gen Virol 1997;78:1663-70.
26. Kanegane H, Bhatia K, Gutiérrez MI, Kaneda H, Wada T, Yachie A, et al. A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma. Blood 1998;91:2085-91.
27. Smir BN, Hauke RJ, Bierman PJ, Gross TG, d'Amore F, Anderson JR, et al. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders. Lab Invest 1996;75:575-88.
28. Bhatia K, Gutiérrez MI, Huppi K, Siwarski D, Magrath IT. The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors. Cancer Res 1992;52:4273-6.
29. Goldschmidts WL, Bhatia K, Johnson J, Akar N, Gutiérrez MI, Shibata D, et al. Epstein-Barr virus genotypes in AIDS associated lymphomas are similar to those in endemic Burkitt's lymphomas. Leukemia 1992;6:875-8.
30. Montalvo EA, Shi Y, Shenk TE, Levine AJ. Negative regulation of the BZLF1 promoter of Epstein-Barr virus. J Virol 1991;65:3647-55.
31. Montalvo EA, Cottam M, Hill S, Wang YJ. YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter. J Virol 1995;69:4158-65.